Cher ML - Search Results

1

Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.

Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML. Nemeth JA, et al. Among authors: cher ml. Cancer Res. 1999 Apr 15;59(8):1987-93. Cancer Res. 1999. PMID: 10213511

2

Diagnostic Performance and Safety of Positron Emission Tomography with ¹⁸F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).

Surasi DS, Eiber M, Maurer T, Preston MA, Helfand BT, Josephson D, Tewari AK, Somford DM, Rais-Bahrami S, Koontz BF, Bostrom PJ, Chau A, Davis P, Schuster DM, Chapin BF; LIGHTHOUSE Study Group. Surasi DS, et al. Eur Urol. 2023 Oct;84(4):361-370. doi: 10.1016/j.eururo.2023.06.018. Epub 2023 Jul 5. Eur Urol. 2023. PMID: 37414702 Free article.

3

Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.

Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. Cher ML, et al. Cancer Res. 1996 Jul 1;56(13):3091-102. Cancer Res. 1996. PMID: 8674067

4

Cher ML, Lewis PE, Banerjee M, Hurley PM, Sakr W, Grignon DJ, Powell IJ. Cher ML, et al. Clin Cancer Res. 1998 May;4(5):1273-8. Clin Cancer Res. 1998. PMID: 9607587

5

Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer.

Gheiler EL, Tefilli MV, Tiguert R, Grignon D, Cher ML, Sakr W, Pontes JE, Wood DP Jr. Gheiler EL, et al. Among authors: cher ml. Urology. 1998 May;51(5):789-95. doi: 10.1016/s0090-4295(98)00096-x. Urology. 1998. PMID: 9610593

6

Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant.

Mueller P, Carroll P, Bowers E, Moore D 2nd, Cher M, Presti J, Wessman M, Pallavicini MG. Mueller P, et al. Cancer. 1998 Aug 1;83(3):538-46. Cancer. 1998. PMID: 9690547

7

Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.

Triest JA, Grignon DJ, Cher ML, Kocheril SV, Montecillo EJ, Talati B, Tekyi-Mensah S, Pontes JE, Hillman GG. Triest JA, et al. Among authors: cher ml. Clin Cancer Res. 1998 Aug;4(8):2009-14. Clin Cancer Res. 1998. PMID: 9717832

8

Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.

Wood DP Jr, Beaman A, Banerjee M, Powell I, Pontes E, Cher ML. Wood DP Jr, et al. Among authors: cher ml. Clin Cancer Res. 1998 Sep;4(9):2119-23. Clin Cancer Res. 1998. PMID: 9748128

9

Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy.

Cher ML, Bianco FJ Jr, Lam JS, Davis LP, Grignon DJ, Sakr WA, Banerjee M, Pontes JE, Wood DP Jr. Cher ML, et al. J Urol. 1998 Oct;160(4):1387-91. J Urol. 1998. PMID: 9751361

10

Chromosomal analysis of renal angiomyolipoma by comparative genomic hybridization: evidence for clonal origin.

Kattar MM, Grignon DJ, Eble JN, Hurley PM, Lewis PE, Sakr WE, Cher ML. Kattar MM, et al. Among authors: cher ml. Hum Pathol. 1999 Mar;30(3):295-9. doi: 10.1016/s0046-8177(99)90008-4. Hum Pathol. 1999. PMID: 10088548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters